Democrats Surge Toward 2026 Midterms as Trump's Grip on Congress Falters

Democrats are heading into the 2026 midterm elections with rising expectations, and a wave election appears increasingly likely, according to multiple analyses [274101][274849]. The November 8 vote could end the Republican Party's control of Washington and give Democrats power to check President Donald Trump, though analysts caution it is still too early to confirm a definitive Democratic wave [274849].

Dr Richard Johnson, Senior Lecturer in US Politics & Policy at Queen Mary University of London, says Democrats could win seats on a scale not seen since Barack Obama's 2008 presidential victory. He points to strong Democratic enthusiasm and growing support among independents, white college-educated voters and Latinos, along with signs that some of Trump's most loyal supporters may be turning away [274757].

Control of the Senate will depend heavily on a handful of close races that could shift the outcome, even as a broader wave appears increasingly likely [274101]. A Democratic victory would challenge Trump's agenda and intensify scrutiny of his administration [274826].

The elections could also reshape how the country handles science. Control of Congress will decide who chairs key committees that oversee research funding, climate policy and public health. A shift in power can slow or speed up laws on drug pricing, energy and artificial intelligence. Scientists and universities are watching closely, because budget decisions and agency leadership often follow election outcomes [274564].

Meanwhile, Health and Human Services Secretary Robert F. Kennedy Jr. is making his case to voters ahead of the midterms, centering his message on fraud, vaccines, and his "Make America Healthy Again" (MAHA) movement. Kennedy is pitching his agenda to an electorate that could decide whether MAHA gains lasting political power or fades [274614]. He is campaigning hard in Iowa for the movement at a time when the U.S. prepares new rules for American investments in Chinese biotech companies [273430].

In Michigan, Democratic Senate candidate Abdul El-Sayed is challenging Kennedy's claims about the Food and Drug Administration's (FDA) new policy on peptides. El-Sayed's response comes as the agency applies what it calls "enforcement discretion" to the regulation of these compounds [274615]. El-Sayed has taken direct aim at Kennedy, saying he wants to "grill" him and calling him the "most incompetent HHS secretary ever" [273417].

For most U.S. elections, voters focus on problems at home, not conflicts abroad. This year is different. Americans are directly connecting the rising cost of gasoline and diesel to the U.S. war in the Middle East, a link that could create serious problems for Trump and Republican candidates in the upcoming midterms [274862].